{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:16:15Z","timestamp":1794431775775,"version":"4.9.1"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41569-025-01242-y","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T02:10:46Z","timestamp":1767319846000},"page":"407-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular imaging of immune and fibrosis targets to guide therapy for repair after myocardial infarction"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-7963","authenticated-orcid":false,"given":"Frank M.","family":"Bengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-3601","authenticated-orcid":false,"given":"Johanna","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Thackeray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc. Res. 117, 1450\u20131488 (2021).","journal-title":"Cardiovasc. Res."},{"key":"1242_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ejhf.1406","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer, R. A. et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. Eur. J. Heart Fail. 21, 272\u2013285 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"1242_CR3","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1161\/CIRCRESAHA.121.318005","volume":"128","author":"JG Rurik","year":"2021","unstructured":"Rurik, J. G., Aghajanian, H. & Epstein, J. A. Immune cells and immunotherapy for cardiac injury and repair. Circ. Res. 128, 1766\u20131779 (2021).","journal-title":"Circ. Res."},{"key":"1242_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/CIRCRESAHA.123.323656","volume":"134","author":"DL Mann","year":"2024","unstructured":"Mann, D. L. The emerging field of cardioimmunology: past, present and foreseeable future. Circ. Res. 134, 1663\u20131680 (2024).","journal-title":"Circ. Res."},{"key":"1242_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2967\/jnumed.123.265670","volume":"64","author":"WA Weber","year":"2023","unstructured":"Weber, W. A. et al. What is theranostics? J. Nucl. Med. 64, 669\u2013670 (2023).","journal-title":"J. Nucl. Med."},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"263s","DOI":"10.2967\/jnumed.120.254532","volume":"61","author":"WA Weber","year":"2020","unstructured":"Weber, W. A. et al. The future of nuclear medicine, molecular imaging, and theranostics. J. Nucl. Med. 61, 263s\u2013272s (2020).","journal-title":"J. Nucl. Med."},{"key":"1242_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger, V. L. Epidemiology of heart failure: a contemporary perspective. Circ. Res. 128, 1421\u20131434 (2021).","journal-title":"Circ. Res."},{"key":"1242_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan, M. S. et al. Global epidemiology of heart failure. Nat. Rev. Cardiol. 21, 717\u2013734 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"1242_CR9","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/RES.0000000000000155","volume":"121","author":"JA Hill","year":"2017","unstructured":"Hill, J. A. et al. Fundamental cardiovascular research: returns on societal investment: a scientific statement from the American Heart Association. Circ. Res. 121, e2\u2013e8 (2017).","journal-title":"Circ. Res."},{"key":"1242_CR10","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","volume":"101","author":"MG Sutton","year":"2000","unstructured":"Sutton, M. G. & Sharpe, N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circ 101, 2981\u20132988 (2000).","journal-title":"Circ"},{"key":"1242_CR11","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M. & Bauersachs, J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur. Heart J. 43, 2549\u20132561 (2022).","journal-title":"Eur. Heart J."},{"key":"1242_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Signaling pathways and targeted therapy for myocardial infarction. Signal. Transduct. Target. Ther. 7, 78 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1242_CR13","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","volume":"122","author":"I Kehat","year":"2010","unstructured":"Kehat, I. & Molkentin, J. D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122, 2727\u20132735 (2010).","journal-title":"Circulation"},{"key":"1242_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-011-0847-y","volume":"90","author":"T Kempf","year":"2012","unstructured":"Kempf, T., Zarbock, A., Vestweber, D. & Wollert, K. C. Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing. J. Mol. Med. 90, 361\u2013369 (2012).","journal-title":"J. Mol. Med."},{"key":"1242_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91\u2013112 (2016).","journal-title":"Circ. Res."},{"key":"1242_CR16","first-page":"187","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans, M. et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 38, 187\u2013197 (2017).","journal-title":"Eur. Heart J."},{"key":"1242_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2024.02.005","volume":"189","author":"S Antipenko","year":"2024","unstructured":"Antipenko, S. et al. Neutrophils are indispensable for adverse cardiac remodeling in heart failure. J. Mol. Cell. Cardiol. 189, 1\u201311 (2024).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1242_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","volume":"124","author":"G Bajpai","year":"2019","unstructured":"Bajpai, G. et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ. Res. 124, 263\u2013278 (2019).","journal-title":"Circ. Res."},{"key":"1242_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003688","volume":"10","author":"SS Bansal","year":"2017","unstructured":"Bansal, S. S. et al. Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure. Circ. Heart Fail. 10, e003688 (2017).","journal-title":"Circ. Heart Fail."},{"key":"1242_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan, X. et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell. Cardiol. 62, 24\u201335 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1242_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","volume":"20","author":"J Yap","year":"2023","unstructured":"Yap, J. et al. Macrophages in cardiac remodelling after myocardial infarction. Nat. Rev. Cardiol. 20, 373\u2013385 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"1242_CR22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/cvr\/cvac113","volume":"119","author":"G Rizzo","year":"2023","unstructured":"Rizzo, G. et al. Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction. Cardiovasc. Res. 119, 772\u2013785 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1242_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32284-2","volume":"13","author":"SH Jung","year":"2022","unstructured":"Jung, S. H. et al. Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts. Nat. Commun. 13, 4580 (2022).","journal-title":"Nat. Commun."},{"key":"1242_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s42003-023-05463-0","volume":"6","author":"JH Siamwala","year":"2023","unstructured":"Siamwala, J. H. et al. IL-1\u03b2-mediated adaptive reprogramming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling. Commun. Biol. 6, 1200 (2023).","journal-title":"Commun. Biol."},{"key":"1242_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766\u2013777 (2022).","journal-title":"Nature"},{"key":"1242_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","volume":"87","author":"J Tillmanns","year":"2015","unstructured":"Tillmanns, J. et al. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J. Mol. Cell. Cardiol. 87, 194\u2013203 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1242_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11307-025-01994-6","volume":"27","author":"A Hess","year":"2025","unstructured":"Hess, A. et al. Spatial FAP expression as detected by 68 Ga-FAPI-46 identifies myofibroblasts beyond the infarct scar after reperfusion. Mol. Imaging Biol. 27, 173\u2013183 (2025).","journal-title":"Mol. Imaging Biol."},{"key":"1242_CR28","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","volume":"60","author":"Z Varasteh","year":"2019","unstructured":"Varasteh, Z. et al. Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J. Nucl. Med. 60, 1743\u20131749 (2019).","journal-title":"J. Nucl. Med."},{"key":"1242_CR29","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1172\/JCI98215","volume":"128","author":"X Fu","year":"2018","unstructured":"Fu, X. et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J. Clin. Invest. 128, 2127\u20132143 (2018).","journal-title":"J. Clin. Invest."},{"key":"1242_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","volume":"635","author":"JM Amrute","year":"2024","unstructured":"Amrute, J. M. et al. Targeting immune-fibroblast cell communication in heart failure. Nature 635, 423\u2013433 (2024).","journal-title":"Nature"},{"key":"1242_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00395-022-00922-x","volume":"117","author":"A Hess","year":"2022","unstructured":"Hess, A., Borchert, T., Ross, T. L., Bengel, F. M. & Thackeray, J. T. Characterizing the transition from immune response to tissue repair after myocardial infarction by multiparametric imaging. Basic Res. Cardiol. 117, 14 (2022).","journal-title":"Basic Res. Cardiol."},{"key":"1242_CR32","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","volume":"41","author":"A Hess","year":"2020","unstructured":"Hess, A. et al. Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. Eur. Heart J. 41, 3564\u20133575 (2020).","journal-title":"Eur. Heart J."},{"key":"1242_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","volume":"45","author":"MA Matter","year":"2024","unstructured":"Matter, M. A. et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur. Heart J. 45, 89\u2013103 (2024).","journal-title":"Eur. Heart J."},{"key":"1242_CR34","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland, O. et al. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur. Heart J. 37, 2406\u20132413 (2016).","journal-title":"Eur. Heart J."},{"key":"1242_CR35","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","volume":"111","author":"A Abbate","year":"2013","unstructured":"Abbate, A. et al. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. Am. J. Cardiol. 111, 1394\u20131400 (2013).","journal-title":"Am. J. Cardiol."},{"key":"1242_CR36","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker, P. M. et al. Low-dose methotrexate for the prevention of atherosclerotic events. N. Engl. J. Med. 380, 752\u2013762 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1242_CR37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","volume":"37","author":"M Schmidt","year":"2016","unstructured":"Schmidt, M. et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for cardiovascular pharmacotherapy of the European Society of Cardiology. Eur. Heart J. 37, 1015\u20131023 (2016).","journal-title":"Eur. Heart J."},{"key":"1242_CR38","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/bph.14155","volume":"175","author":"S Huang","year":"2018","unstructured":"Huang, S. & Frangogiannis, N. G. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br. J. Pharmacol. 175, 1377\u20131400 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"1242_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cardiores.2004.10.014","volume":"65","author":"XM Gao","year":"2005","unstructured":"Gao, X. M., Xu, Q., Kiriazis, H., Dart, A. M. & Du, X. J. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc. Res. 65, 469\u2013477 (2005).","journal-title":"Cardiovasc. Res."},{"key":"1242_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"BM Everett","year":"2019","unstructured":"Everett, B. M. et al. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139, 1289\u20131299 (2019).","journal-title":"Circulation"},{"key":"1242_CR41","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1093\/eurheartj\/ehae538","volume":"45","author":"D Pascual-Figal","year":"2024","unstructured":"Pascual-Figal, D. et al. Colchicine in acutely decompensated heart failure: the colica trial. Eur. Heart J. 45, 4826\u20134836 (2024).","journal-title":"Eur. Heart J."},{"key":"1242_CR42","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.3284","volume":"19","author":"Y Zouggari","year":"2013","unstructured":"Zouggari, Y. et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19, 1273\u20131280 (2013).","journal-title":"Nat. Med."},{"key":"1242_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/eurheartj\/ehq446","volume":"32","author":"FA Flachskampf","year":"2011","unstructured":"Flachskampf, F. A. et al. Cardiac imaging after myocardial infarction. Eur. Heart J. 32, 272\u2013283 (2011).","journal-title":"Eur. Heart J."},{"key":"1242_CR44","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jacc.2010.06.044","volume":"56","author":"CL Hung","year":"2010","unstructured":"Hung, C. L. et al. Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J. Am. Coll. Cardiol. 56, 1812\u20131822 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","volume":"11","author":"E Potter","year":"2018","unstructured":"Potter, E. & Marwick, T. H. Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc. Imaging 11, 260\u2013274 (2018).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1242_CR46","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jacc.2020.06.076","volume":"76","author":"KM Abdelrahman","year":"2020","unstructured":"Abdelrahman, K. M. et al. Coronary computed tomography angiography from clinical uses to emerging technologies: JACC state-of-the-art review. J. Am. Coll. Cardiol. 76, 1226\u20131243 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/heartjnl-2021-319773","volume":"108","author":"BL N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard, B. L. et al. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. Heart 108, 194\u2013202 (2022).","journal-title":"Heart"},{"key":"1242_CR48","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jcct.2022.07.002","volume":"16","author":"RC Cury","year":"2022","unstructured":"Cury, R. C. et al. CAD-RADS\u2122 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: an expert consensus document of the Ssociety of Cardiovascular Computed Comography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). J. Cardiovasc. Comput. Tomogr. 16, 536\u2013557 (2022).","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"1242_CR49","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/heartjnl-2022-321360","volume":"109","author":"C Greer","year":"2023","unstructured":"Greer, C., Williams, M. C., Newby, D. E. & Adamson, P. D. Role of computed tomography cardiac angiography in acute chest pain syndromes. Heart 109, 1350\u20131356 (2023).","journal-title":"Heart"},{"key":"1242_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/eurheartj\/ehq409","volume":"32","author":"M Perazzolo Marra","year":"2011","unstructured":"Perazzolo Marra, M., Lima, J. A. & Iliceto, S. MRI in acute myocardial infarction. Eur. Heart J. 32, 284\u2013293 (2011).","journal-title":"Eur. Heart J."},{"key":"1242_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez, B. et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119\u2013177 (2018).","journal-title":"Eur. Heart J."},{"key":"1242_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1148\/radiol.2021204265","volume":"301","author":"CWH Beijnink","year":"2021","unstructured":"Beijnink, C. W. H. et al. Cardiac MRI to visualize myocardial damage after ST-segment elevation myocardial infarction: a review of its histologic validation. Radiology 301, 4\u201318 (2021).","journal-title":"Radiology"},{"key":"1242_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12968-022-00866-0","volume":"24","author":"AT O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, A. T., Gil, K. E., Varghese, J., Simonetti, O. P. & Zareba, K. M. T2 mapping in myocardial disease: a comprehensive review. J. Cardiovasc. Magn. Reson. 24, 33 (2022).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1242_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007453","volume":"11","author":"IT Ramos","year":"2018","unstructured":"Ramos, I. T. et al. Simultaneous assessment of cardiac inflammation and extracellular matrix remodeling after myocardial infarction. Circ. Cardiovasc. Imaging 11, e007453 (2018).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1242_CR55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3174\/ajnr.A4615","volume":"37","author":"J Ramalho","year":"2016","unstructured":"Ramalho, J. et al. Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am. J. Neuroradiol. 37, 1192\u20131198 (2016).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1242_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40263-018-0500-1","volume":"32","author":"L Pasquini","year":"2018","unstructured":"Pasquini, L. et al. Gadolinium-based contrast agent-related toxicities. CNS Drugs 32, 229\u2013240 (2018).","journal-title":"CNS Drugs"},{"key":"1242_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","volume":"71","author":"JT Thackeray","year":"2018","unstructured":"Thackeray, J. T. et al. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction. J. Am. Coll. Cardiol. 71, 263\u2013275 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR58","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","volume":"124","author":"GS Heo","year":"2019","unstructured":"Heo, G. S. et al. Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circ. Res. 124, 881\u2013890 (2019).","journal-title":"Circ. Res."},{"key":"1242_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11886-018-0955-1","volume":"20","author":"JT Thackeray","year":"2018","unstructured":"Thackeray, J. T. PET assessment of immune cell activity and therapeutic monitoring following myocardial infarction. Curr. Cardiol. Rep. 20, 13 (2018).","journal-title":"Curr. Cardiol. Rep."},{"key":"1242_CR60","doi-asserted-by":"publisher","first-page":"39s","DOI":"10.2967\/jnumed.122.264865","volume":"64","author":"JT Thackeray","year":"2023","unstructured":"Thackeray, J. T., Lavine, K. J. & Liu, Y. Imaging inflammation past, present, and future: focus on cardioimmunology. J. Nucl. Med. 64, 39s\u201348s (2023).","journal-title":"J. Nucl. Med."},{"key":"1242_CR61","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jacbts.2022.12.014","volume":"8","author":"A Maier","year":"2023","unstructured":"Maier, A. et al. Multiparametric immunoimaging maps inflammatory signatures in murine myocardial infarction models. JACC Basic Transl. Sci. 8, 801\u2013816 (2023).","journal-title":"JACC Basic Transl. Sci."},{"key":"1242_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41586-024-08441-6","volume":"639","author":"A Salehi Farid","year":"2025","unstructured":"Salehi Farid, A. et al. CD45-PET is a robust, non-invasive tool for imaging inflammation. Nature 639, 214\u2013224 (2025).","journal-title":"Nature"},{"key":"1242_CR63","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","volume":"77","author":"J Diekmann","year":"2021","unstructured":"Diekmann, J. et al. Molecular imaging identifies fibroblast activation beyond the infarct region after acute myocardial infarction. J. Am. Coll. Cardiol. 77, 1835\u20131837 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR64","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.7150\/thno.51419","volume":"11","author":"LBN Langer","year":"2021","unstructured":"Langer, L. B. N. et al. Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [68Ga]MHLL1. Theranostics 11, 7755\u20137766 (2021).","journal-title":"Theranostics"},{"key":"1242_CR65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11886-023-01869-8","volume":"25","author":"MF Mayola","year":"2023","unstructured":"Mayola, M. F. & Thackeray, J. T. The potential of fibroblast activation protein-targeted imaging as a biomarker of cardiac remodeling and injury. Curr. Cardiol. Rep. 25, 515\u2013523 (2023).","journal-title":"Curr. Cardiol. Rep."},{"key":"1242_CR66","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","volume":"63","author":"J Diekmann","year":"2022","unstructured":"Diekmann, J. et al. Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome. J. Nucl. Med. 63, 1415\u20131423 (2022).","journal-title":"J. Nucl. Med."},{"key":"1242_CR67","doi-asserted-by":"publisher","first-page":"1s","DOI":"10.2967\/jnumed.123.266845","volume":"64","author":"FM Bengel","year":"2023","unstructured":"Bengel, F. M. & Di Carli, M. F. The evolution of cardiac nuclear imaging. J. Nucl. Med. 64, 1s\u20132s (2023).","journal-title":"J. Nucl. Med."},{"key":"1242_CR68","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jcmg.2023.06.022","volume":"16","author":"SR Cherry","year":"2023","unstructured":"Cherry, S. R., Diekmann, J. & Bengel, F. M. Total-body positron emission tomography: adding new perspectives to cardiovascular research. JACC Cardiovasc. Imaging 16, 1335\u20131347 (2023).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1242_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6169","volume":"9","author":"SR Cherry","year":"2017","unstructured":"Cherry, S. R. et al. Total-body imaging: transforming the role of positron emission tomography. Sci. Transl. Med. 9, eaaf6169 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1242_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jacc.2011.08.066","volume":"59","author":"WW Lee","year":"2012","unstructured":"Lee, W. W. et al. PET\/MRI of inflammation in myocardial infarction. J. Am. Coll. Cardiol. 59, 153\u2013163 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR71","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/CIRCIMAGING.114.001689","volume":"7","author":"T Wollenweber","year":"2014","unstructured":"Wollenweber, T. et al. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging. Circ. Cardiovasc. Imaging 7, 811\u2013818 (2014).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1242_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00259-014-2884-6","volume":"42","author":"JT Thackeray","year":"2015","unstructured":"Thackeray, J. T. et al. Targeting post-infarct inflammation by PET imaging: comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model. Eur. J. Nucl. Med. Mol. Imaging 42, 317\u2013327 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1242_CR73","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.7150\/thno.15929","volume":"6","author":"JT Thackeray","year":"2016","unstructured":"Thackeray, J. T., Bankstahl, J. P., Wang, Y., Wollert, K. C. & Bengel, F. M. Targeting amino acid metabolism for molecular imaging of inflammation early after myocardial infarction. Theranostics 6, 1768\u20131779 (2016).","journal-title":"Theranostics"},{"key":"1242_CR74","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2967\/jnumed.108.061341","volume":"50","author":"M Morooka","year":"2009","unstructured":"Morooka, M. et al. 11C-methionine PET of acute myocardial infarction. J. Nucl. Med. 50, 1283\u20131287 (2009).","journal-title":"J. Nucl. Med."},{"key":"1242_CR75","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.jacc.2019.02.052","volume":"73","author":"JM Tarkin","year":"2019","unstructured":"Tarkin, J. M. et al. 68Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction. J. Am. Coll. Cardiol. 73, 2489\u20132491 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR76","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.122.014538","volume":"16","author":"A \u0106orovi\u0107","year":"2023","unstructured":"\u0106orovi\u0107, A. et al. Novel approach for assessing postinfarct myocardial injury and inflammation using hybrid somatostatin receptor positron emission tomography\/magnetic resonance imaging. Circ. Cardiovasc. Imaging 16, e014538 (2023).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1242_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","volume":"194","author":"C Lapa","year":"2015","unstructured":"Lapa, C. et al. Imaging of myocardial inflammation with somatostatin receptor based PET\/CT \u2014 a comparison to cardiac MRI. Int. J. Cardiol. 194, 44\u201349 (2015).","journal-title":"Int. J. Cardiol."},{"key":"1242_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09590-2","volume":"12","author":"YC Toner","year":"2022","unstructured":"Toner, Y. C. et al. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation. Sci. Rep. 12, 6185 (2022).","journal-title":"Sci. Rep."},{"key":"1242_CR79","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2967\/jnumed.119.241356","volume":"61","author":"A Jahandideh","year":"2020","unstructured":"Jahandideh, A. et al. Folate receptor \u03b2-targeted PET imaging of macrophages in autoimmune myocarditis. J. Nucl. Med. 61, 1643\u20131649 (2020).","journal-title":"J. Nucl. Med."},{"key":"1242_CR80","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2019.03.011","volume":"284","author":"C Kopecky","year":"2019","unstructured":"Kopecky, C. et al. Translocator protein localises to CD11b+ macrophages in atherosclerosis. Atherosclerosis 284, 153\u2013159 (2019).","journal-title":"Atherosclerosis"},{"key":"1242_CR81","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2967\/jnumed.120.243600","volume":"62","author":"MG MacAskill","year":"2021","unstructured":"MacAskill, M. G. et al. Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism. J. Nucl. Med. 62, 536\u2013544 (2021).","journal-title":"J. Nucl. Med."},{"key":"1242_CR82","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00259-020-04736-8","volume":"47","author":"T Borchert","year":"2020","unstructured":"Borchert, T. et al. Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. Eur. J. Nucl. Med. Mol. Imaging 47, 1757\u20131768 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1242_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40937-z","volume":"14","author":"E Nutma","year":"2023","unstructured":"Nutma, E. et al. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases. Nat. Commun. 14, 5247 (2023).","journal-title":"Nat. Commun."},{"key":"1242_CR84","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1016\/j.cell.2023.07.009","volume":"186","author":"ZI Kolabas","year":"2023","unstructured":"Kolabas, Z. I. et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell 186, 3706\u20133725.e29 (2023).","journal-title":"Cell"},{"key":"1242_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34451-2","volume":"8","author":"PN Thai","year":"2018","unstructured":"Thai, P. N. et al. Cardiac-specific conditional knockout of the 18-kDa mitochondrial translocator protein protects from pressure overload induced heart failure. Sci. Rep. 8, 16213 (2018).","journal-title":"Sci. Rep."},{"key":"1242_CR86","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s12350-019-01929-z","volume":"28","author":"T Borchert","year":"2021","unstructured":"Borchert, T. et al. Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals. J. Nucl. Cardiol. 28, 1636\u20131645 (2021).","journal-title":"J. Nucl. Cardiol."},{"key":"1242_CR87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.122.014071","volume":"16","author":"LM Wienecke","year":"2023","unstructured":"Wienecke, L. M., Leid, J. M., Leuschner, F. & Lavine, K. J. Imaging targets to visualize the cardiac immune landscape in heart failure. Circ. Cardiovasc. Imaging 16, e014071 (2023).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1242_CR88","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","volume":"8","author":"JT Thackeray","year":"2015","unstructured":"Thackeray, J. T. et al. Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction. JACC Cardiovasc. Imaging 8, 1417\u20131426 (2015).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1242_CR89","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jcmg.2021.08.013","volume":"15","author":"RA Werner","year":"2022","unstructured":"Werner, R. A. et al. CXCR4-targeted imaging of post-infarct myocardial tissue inflammation: prognostic value after reperfused myocardial infarction. JACC Cardiovasc. Imaging 15, 372\u2013374 (2022).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1242_CR90","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai, G. et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat. Med. 24, 1234\u20131245 (2018).","journal-title":"Nat. Med."},{"key":"1242_CR91","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2967\/jnumed.120.244673","volume":"62","author":"GS Heo","year":"2021","unstructured":"Heo, G. S. et al. Targeted PET imaging of chemokine receptor 2-positive monocytes and macrophages in the injured heart. J. Nucl. Med. 62, 111\u2013114 (2021).","journal-title":"J. Nucl. Med."},{"key":"1242_CR92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1164\/rccm.202004-1132OC","volume":"203","author":"SL Brody","year":"2021","unstructured":"Brody, S. L. et al. Chemokine receptor 2-targeted molecular imaging in pulmonary fibrosis. A clinical trial. Am. J. Respir. Crit. Care Med. 203, 78\u201389 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1242_CR93","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nm.3437","volume":"20","author":"N Tahara","year":"2014","unstructured":"Tahara, N. et al. 2-Deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat. Med. 20, 215\u2013219 (2014).","journal-title":"Nat. Med."},{"key":"1242_CR94","doi-asserted-by":"publisher","first-page":"889963","DOI":"10.3389\/fcvm.2022.889963","volume":"9","author":"Z Varasteh","year":"2022","unstructured":"Varasteh, Z. et al. In vivo visualization of M2 macrophages in the myocardium after myocardial infarction (MI) using 68Ga-NOTA-anti-MMR Nb: targeting mannose receptor (MR, CD206) on M2 macrophages. Front. Cardiovasc. Med. 9, 889963 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1242_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14064","volume":"8","author":"EJ Keliher","year":"2017","unstructured":"Keliher, E. J. et al. Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. Nat. Commun. 8, 14064 (2017).","journal-title":"Nat. Commun."},{"key":"1242_CR96","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.010586","volume":"13","author":"M Nahrendorf","year":"2020","unstructured":"Nahrendorf, M. et al. Imaging cardiovascular and lung macrophages with the positron emission tomography sensor 64Cu-macrin in mice, rabbits, and pigs. Circ. Cardiovasc. Imaging 13, e010586 (2020).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1242_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe7853","volume":"7","author":"MMT van Leent","year":"2021","unstructured":"van Leent, M. M. T. et al. A modular approach toward producing nanotherapeutics targeting the innate immune system. Sci. Adv. 7, eabe7853 (2021).","journal-title":"Sci. Adv."},{"key":"1242_CR98","doi-asserted-by":"publisher","first-page":"104885","DOI":"10.1016\/j.yrtph.2021.104885","volume":"122","author":"J Allan","year":"2021","unstructured":"Allan, J. et al. Regulatory landscape of nanotechnology and nanoplastics from a global perspective. Regul. Toxicol. Pharmacol. 122, 104885 (2021).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"1242_CR99","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1158\/0008-5472.CAN-19-3265","volume":"80","author":"Z Xiao","year":"2020","unstructured":"Xiao, Z., Mayer, A. T., Nobashi, T. W. & Gambhir, S. S. ICOS is an indicator of T-cell-mediated response to cancer immunotherapy. Cancer Res. 80, 3023\u20133032 (2020).","journal-title":"Cancer Res."},{"key":"1242_CR100","doi-asserted-by":"publisher","first-page":"799910","DOI":"10.3389\/fimmu.2021.799910","volume":"12","author":"B Traenkle","year":"2021","unstructured":"Traenkle, B. et al. Single-domain antibodies for targeting, detection, and in vivo imaging of human CD4+ cells. Front. Immunol. 12, 799910 (2021).","journal-title":"Front. Immunol."},{"key":"1242_CR101","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.20161950","volume":"214","author":"M Rashidian","year":"2017","unstructured":"Rashidian, M. et al. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J. Exp. Med. 214, 2243\u20132255 (2017).","journal-title":"J. Exp. Med."},{"key":"1242_CR102","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11307-024-01932-y","volume":"26","author":"UM Shrestha","year":"2024","unstructured":"Shrestha, U. M. et al. A feasibility study of [18F]F-AraG positron emission tomography (PET) for cardiac imaging-myocardial viability in ischemia-reperfusion injury model. Mol. Imaging Biol. 26, 869\u2013878 (2024).","journal-title":"Mol. Imaging Biol."},{"key":"1242_CR103","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00259-023-06521-9","volume":"51","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Granzyme B PET imaging inflammation and remodeling in myocardial infarction. Eur. J. Nucl. Med. Mol. Imaging 51, 991\u20131001 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1242_CR104","doi-asserted-by":"publisher","first-page":"109828","DOI":"10.1016\/j.cellsig.2020.109828","volume":"77","author":"S Smolgovsky","year":"2021","unstructured":"Smolgovsky, S., Ibeh, U., Tamayo, T. P. & Alcaide, P. Adding insult to injury \u2014 inflammation at the heart of cardiac fibrosis. Cell. Signal. 77, 109828 (2021).","journal-title":"Cell. Signal."},{"key":"1242_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005585","volume":"4","author":"J Muzard","year":"2009","unstructured":"Muzard, J. et al. Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI. PLoS One 4, e5585 (2009).","journal-title":"PLoS One"},{"key":"1242_CR106","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00726-016-2328-7","volume":"49","author":"L Zheng","year":"2017","unstructured":"Zheng, L. et al. Molecular imaging of fibrosis using a novel collagen-binding peptide labelled with 99mTc on SPECT\/CT. J. Amino Acids 49, 89\u2013101 (2017).","journal-title":"J. Amino Acids"},{"key":"1242_CR107","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1021\/acs.molpharmaceut.2c00551","volume":"19","author":"P Qiao","year":"2022","unstructured":"Qiao, P. et al. Noninvasive monitoring of reparative fibrosis after myocardial infarction in rats using 68Ga-FAPI-04 PET\/CT. Mol. Pharm. 19, 4171\u20134178 (2022).","journal-title":"Mol. Pharm."},{"key":"1242_CR108","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2967\/jnumed.123.266526","volume":"65","author":"M Strunk","year":"2024","unstructured":"Strunk, M. et al. Toward quantitative multisite preclinical imaging studies in acute myocardial infarction: evaluation of the immune-fibrosis axis. J. Nucl. Med. 65, 287\u2013293 (2024).","journal-title":"J. Nucl. Med."},{"key":"1242_CR109","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","volume":"85","author":"AK Barton","year":"2025","unstructured":"Barton, A. K. et al. Myocardial fibroblast activation after acute myocardial infarction: a positron emission tomography and magnetic resonance study. J. Am. Coll. Cardiol. 85, 578\u2013591 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR110","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430\u2013433 (2019).","journal-title":"Nature"},{"key":"1242_CR111","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. Car T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"1242_CR112","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi8986","volume":"9","author":"LM Bartos","year":"2023","unstructured":"Bartos, L. M. et al. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution. Sci. Adv. 9, eadi8986 (2023).","journal-title":"Sci. Adv."},{"key":"1242_CR113","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/CIRCRESAHA.120.318539","volume":"129","author":"A Glasenapp","year":"2021","unstructured":"Glasenapp, A. et al. Molecular imaging of inflammation and fibrosis in pressure overload heart failure. Circ. Res. 129, 369\u2013382 (2021).","journal-title":"Circ. Res."},{"key":"1242_CR114","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00259-022-05984-6","volume":"50","author":"G Wang","year":"2023","unstructured":"Wang, G. et al. Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET\/CT. Eur. J. Nucl. Med. Mol. Imaging 50, 465\u2013474 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1242_CR115","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2967\/jnumed.122.265147","volume":"64","author":"J Diekmann","year":"2023","unstructured":"Diekmann, J. et al. Molecular imaging of myocardial fibroblast activation in patients with advanced aortic stenosis before transcatheter aortic valve replacement: a pilot study. J. Nucl. Med. 64, 1279\u20131286 (2023).","journal-title":"J. Nucl. Med."},{"key":"1242_CR116","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/cells13040327","volume":"13","author":"MB Dewar","year":"2024","unstructured":"Dewar, M. B. et al. Defining transcriptomic heterogeneity between left and right ventricle-derived cardiac fibroblasts. Cells 13, 327 (2024).","journal-title":"Cells"},{"key":"1242_CR117","doi-asserted-by":"publisher","first-page":"102106","DOI":"10.1016\/j.nuclcard.2024.102106","volume":"47","author":"K Loganath","year":"2025","unstructured":"Loganath, K. et al. Cardiovascular positron emission tomography imaging of fibroblast activation: a review of the current literature. J. Nucl. Cardiol. 47, 102106 (2025).","journal-title":"J. Nucl. Cardiol."},{"key":"1242_CR118","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.cell.2024.05.015","volume":"187","author":"M Kamiya","year":"2024","unstructured":"Kamiya, M. et al. Immune mechanisms in fibrotic interstitial lung disease. Cell 187, 3506\u20133530 (2024).","journal-title":"Cell"},{"key":"1242_CR119","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest. 127, 55\u201364 (2017).","journal-title":"J. Clin. Invest."},{"key":"1242_CR120","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang, R., Fu, P. & Ma, L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal. Transduct. Target. Ther. 8, 129 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1242_CR121","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.2967\/jnumed.124.268363","volume":"65","author":"J Calais","year":"2024","unstructured":"Calais, J. et al. Best patient care practices for administering PSMA-targeted radiopharmaceutical therapy. J. Nucl. Med. 65, 1666\u20131671 (2024).","journal-title":"J. Nucl. Med."},{"key":"1242_CR122","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"1242_CR123","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jcmg.2015.09.007","volume":"8","author":"C Lapa","year":"2015","unstructured":"Lapa, C. et al. [68Ga]pentixafor-PET\/CT for imaging of chemokine receptor 4 expression after myocardial infarction. JACC Cardiovasc. Imaging 8, 1466\u20131468 (2015).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1242_CR124","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0735-1097(02)02136-8","volume":"40","author":"DP Faxon","year":"2002","unstructured":"Faxon, D. P., Gibbons, R. J., Chronos, N. A., Gurbel, P. A. & Sheehan, F. The effect of blockade of the CD11\/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J. Am. Coll. Cardiol. 40, 1199\u20131204 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR125","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.2016.3609","volume":"315","author":"ML O\u2019Donoghue","year":"2016","unstructured":"O\u2019Donoghue, M. L. et al. Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial. JAMA 315, 1591\u20131599 (2016).","journal-title":"JAMA"},{"key":"1242_CR126","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0735-1097(01)01613-8","volume":"38","author":"HV Barron","year":"2001","unstructured":"Barron, H. V., Harr, S. D., Radford, M. J., Wang, Y. & Krumholz, H. M. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J. Am. Coll. Cardiol. 38, 1654\u20131661 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR127","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","volume":"35","author":"C Heeschen","year":"2000","unstructured":"Heeschen, C., Hamm, C. W., Bruemmer, J. & Simoons, M. L. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE investigators. Chimeric C7E3 antiplatelet therapy in unstable angina refractory to standard treatment trial. J. Am. Coll. Cardiol. 35, 1535\u20131542 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1242_CR128","doi-asserted-by":"publisher","first-page":"132044","DOI":"10.1016\/j.ijcard.2024.132044","volume":"406","author":"J Tillmanns","year":"2024","unstructured":"Tillmanns, J. et al. Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation. Int. J. Cardiol. 406, 132044 (2024).","journal-title":"Int. J. Cardiol."},{"key":"1242_CR129","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati, E. et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ. Heart Fail. 13, e007405 (2020).","journal-title":"Circ. Heart Fail."},{"key":"1242_CR130","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10741-022-10247-5","volume":"28","author":"A Porcari","year":"2023","unstructured":"Porcari, A. et al. Endomyocardial biopsy in the clinical context: current indications and challenging scenarios. Heart Fail. Rev. 28, 123\u2013135 (2023).","journal-title":"Heart Fail. Rev."},{"key":"1242_CR131","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","volume":"28","author":"LT Cooper","year":"2007","unstructured":"Cooper, L. T. et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur. Heart J. 28, 3076\u20133093 (2007).","journal-title":"Eur. Heart J."},{"key":"1242_CR132","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/ehjci\/jead128","volume":"24","author":"A Saraste","year":"2023","unstructured":"Saraste, A., Knuuti, J. & Bengel, F. Phenotyping heart failure by nuclear imaging of myocardial perfusion, metabolism, and molecular targets. Eur. Heart J. Cardiovasc. Imaging 24, 1318\u20131328 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1242_CR133","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta, P. et al. Myocardial infarction accelerates atherosclerosis. Nature 487, 325\u2013329 (2012).","journal-title":"Nature"},{"key":"1242_CR134","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-024-07469-y","volume":"630","author":"H Jin","year":"2024","unstructured":"Jin, H., Li, M., Jeong, E., Castro-Martinez, F. & Zuker, C. S. A body-brain circuit that regulates body inflammatory responses. Nature 630, 695\u2013703 (2024).","journal-title":"Nature"},{"key":"1242_CR135","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaneurol.2023.1331","volume":"80","author":"MC Johansen","year":"2023","unstructured":"Johansen, M. C. et al. Association between acute myocardial infarction and cognition. JAMA Neurol. 80, 723\u2013731 (2023).","journal-title":"JAMA Neurol."},{"key":"1242_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93379-6","volume":"15","author":"D Luo","year":"2025","unstructured":"Luo, D. et al. Association between mild renal insufficiency, inflammatory status on initial admission, and 1-year mortality following ST-segment elevation myocardial infarction. Sci. Rep. 15, 11075 (2025).","journal-title":"Sci. Rep."},{"key":"1242_CR137","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.cmet.2024.06.009","volume":"36","author":"W Xie","year":"2024","unstructured":"Xie, W. et al. Myocardial infarction accelerates the progression of mash by triggering immunoinflammatory response and induction of periostin. Cell Metab. 36, 1634 (2024).","journal-title":"Cell Metab."},{"key":"1242_CR138","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0140-6736(16)31714-7","volume":"389","author":"A Tawakol","year":"2017","unstructured":"Tawakol, A. et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 389, 834\u2013845 (2017).","journal-title":"Lancet"},{"key":"1242_CR139","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001920","volume":"4","author":"A Meissner","year":"2015","unstructured":"Meissner, A. et al. Tumor necrosis factor-\u03b1 underlies loss of cortical dendritic spine density in a mouse model of congestive heart failure. J. Am. Heart Assoc. 4, e001920 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"1242_CR140","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.7150\/thno.61423","volume":"11","author":"RA Werner","year":"2021","unstructured":"Werner, R. A. et al. Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction. Theranostics 11, 7984\u20137994 (2021).","journal-title":"Theranostics"},{"key":"1242_CR141","first-page":"62","volume":"11","author":"T Chiuariu","year":"2024","unstructured":"Chiuariu, T. et al. Cardiac and renal fibrosis, the silent killer in the cardiovascular continuum: an up-to-date. J. Cardiovasc. Dev. Dis. 11, 62 (2024).","journal-title":"J. Cardiovasc. Dev. Dis."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01242-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:03:49Z","timestamp":1779278629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1038\/s41569-025-01242-y","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"21 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}